
ZVRA
Healthcare · Biotechnology · $540.3M market cap
$9.08-2.08 (-18.6%)Nov 13, 4:26 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -9.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 3, 2026 | After the close | 0.14 | 0.18 | +28.6% |
| Aug 5, 2026 | After the close | 0.08 | 0.25 | +212.5% |
| May 6, 2026 | After the close | 0.08 | 0.18 | +125.0% |
| Mar 11, 2026 | Time not confirmed | 0.05 | 0.19 | +280.0% |
| Nov 5, 2025 | After the close | -0.04 | -0.01 | +75.0% |
| Aug 12, 2025 | After the close | 1.38 | -0.06 | -104.3% |
| May 13, 2025 | After the close | -0.18 | -0.06 | +66.7% |
| Mar 26, 2025 | After the close | -0.40 | -0.69 | -73.1% |
| Nov 12, 2024 | After the close | -0.41 | -0.69 | -68.3% |
| Aug 13, 2024 | After the close | -0.44 | -0.48 | -9.1% |
| May 8, 2024 | Before the open | -0.48 | -0.40 | +16.7% |
| Mar 5, 2024 | After the close | -0.27 | -0.40 | -48.1% |
| Nov 7, 2023 | Before the open | -0.30 | -0.40 |
Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 3 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase 3 clinical…
| -33.3% |
| Aug 14, 2023 | Before the open | -0.34 | -0.15 | +55.9% |
| May 15, 2023 | After the close | -0.23 | -0.34 | -47.8% |
| Mar 7, 2023 | Before the open | -0.17 | -0.26 | -52.9% |
| Nov 9, 2022 | After the close | -0.10 | -0.19 | -90.0% |
| Aug 11, 2022 | After the close | -0.14 | -0.70 | -400.0% |
| May 12, 2022 | After the close | -0.05 | -0.05 | 0.0% |
| Mar 30, 2022 | After the close | -0.07 | -0.08 | -14.3% |
| Nov 10, 2021 | After the close | -0.08 | -0.05 | +37.5% |
| Aug 12, 2021 | After the close | 0.23 | -0.40 | -273.9% |
| May 13, 2021 | After the close | -0.17 | -1.61 | -847.1% |
| Mar 11, 2021 | After the close | -0.64 | -1.07 | -67.2% |
| Oct 29, 2020 | After the close | -0.80 | -0.64 | +20.0% |
| Aug 12, 2020 | After the close | -0.02 | 0.16 | +900.0% |
| May 12, 2020 | After the close | -1.76 | -1.92 | -9.1% |
| Feb 28, 2020 | Before the open | -1.36 | -0.16 | +88.2% |
| Nov 14, 2019 | After the close | -4.48 | 0.96 | +121.4% |
| Aug 13, 2019 | After the close | -6.80 | -5.28 | +22.4% |
| May 14, 2019 | After the close | -7.36 | -7.36 | 0.0% |
| Feb 28, 2019 | After the close | -7.60 | -3.20 | +57.9% |
| Nov 8, 2018 | After the close | -12.32 | -13.41 | -8.8% |
| Aug 9, 2018 | After the close | -15.42 | -10.40 | +32.6% |
| May 10, 2018 | After the close | -11.04 | -28.32 | -156.5% |
| Mar 29, 2018 | After the close | -10.96 | -11.52 | -5.1% |